Tumour maintenance is mediated by eNOS

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Tumour cells rely on oncogenes like Ras for growth.
• Mutated Ras proteins are constitutively active in many cancers.
• Oncogenic Ras activates pathways, including PI3K-AKT, to sustain tumour growth.

Purpose of the Study:

• To investigate the role of endothelial nitric oxide synthase (eNOS) in oncogenic Ras-driven tumour growth.
• To determine if blocking eNOS phosphorylation affects tumour initiation and maintenance.

Main Methods:

• Focus on blocking the phosphorylation of the AKT substrate, eNOS.
• Analysis of eNOS's role in nitrosylation and activation of wild-type Ras proteins.
• Inhibition studies targeting the PI3K-AKT-eNOS pathway.

Main Results:

• Blocking eNOS phosphorylation effectively inhibits both tumour initiation and maintenance.
• eNOS was found to enhance the nitrosylation and activation of endogenous wild-type Ras proteins.
• This activation of wild-type Ras by eNOS is essential throughout tumorigenesis.

Conclusions:

• The PI3K-AKT-eNOS-(wild-type) Ras pathway is critical for tumour growth.
• Oncogenic Ras activates this pathway to initiate and maintain tumour development.
• Targeting eNOS phosphorylation presents a potential therapeutic strategy for cancers driven by Ras.